SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: berblady who wrote (50)3/4/2001 5:54:06 PM
From: dmkst1  Read Replies (1) of 222
 
berblady

that info was available on the IDPH conference call in late jan/early feb - at that time IDPH said they were going to have their mid cycle review in middle of feb and that review dates can be set after that - they also discussed the mechanism for the cancellation of the meeting being that the contents of the meeting have to be posted in the federal register a certain time period before the meeting - the FDA did not send any notice to the federal reigster about what would happen at that meeting and therefore the meeting had to be cancelled.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News